Mouwasat Medical Services Co. intrinsic value and dividend analysis using DCF, P/B, PEG and PSG models. Includes dividend yield, payout ratio, and dividend sustainability assessment. Sector: Health Care Equipment & Svc. Listed on Saudi Exchange Tadawul.
Mouwasat Medical Services Company acquires, manages, and operates a network of hospitals, medical centers, and pharmacies in Saudi Arabia. Its hospitals include specialized centers for ophthalmology, cardiology, fertility, and rehabilitation, alongside inpatient pharmacy and chemotherapy preparation services. The company was founded in 1974 and is based in Dammam.
TASIV estimates this company's intrinsic value using a DCF (Discounted Cash Flow) model. As of TASIV's most recent data refresh, the estimated intrinsic value is SAR 110.83 compared to a market price of SAR 65.70 (Trading significantly below DCF model value). This is an analytical estimate, not investment advice.
Revenue increased by about 19% over the three-year period, while net income grew at a faster rate of approximately 25%, indicating that profitability increased faster than sales. Operating cash flow increased by about 45%, outpacing both revenue and net income growth. Overall, the company's historical financial performance shows an increase in revenue, profitability, and operating cash flow over the period, with cash generation growing the fastest of the three.
Dividend per share fluctuated over the 5-year recorded period, ranging between SAR 1 and SAR 5.75, and ended at SAR 1.125 versus SAR 5.75 at the start. Payments have been made on an Annual basis throughout this period. Overall, the company's per-share dividend has varied year to year without a consistent direction. Current dividend yield is approximately 1.71%, with a payout ratio of approximately 27.37%.
TASIV's Competitive Advantage assessment for this company is High (91/100), based on profitability, predictability, financial strength, and growth resilience.
This company currently meets the following TASIV screener criteria: Value Screener.
Based on TASIV's DCF (Discounted Cash Flow) model, the estimated intrinsic value of Mouwasat Medical Services Co. is approximately SAR 110.83, compared to a current market price of SAR 65.70. This is an analytical estimate based on the company's financial data, not investment advice or a recommendation to buy or sell.
According to TASIV's model, Mouwasat Medical Services Co. is currently "Trading significantly below DCF model value".
Mouwasat Medical Services Co.'s dividend yield is approximately 1.71%, with a payout ratio of approximately 27.37%, based on TASIV's most recent verified data.
Loading 4002...